LENACAPAVIR vs LERCANIDIPINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LENACAPAVIR vs LERCANIDIPINE: Safety Overview
| Metric | LENACAPAVIR | LERCANIDIPINE |
|---|---|---|
| Total FAERS Reports | 502 | 3,767 |
| Deaths Reported | 32 | 248 |
| Death Rate | 6.4% | 6.6% |
| Hospitalizations | 42 | 2,249 |
| Average Patient Age | 50.0 yrs | 65.8 yrs |
| % Female Patients | 24.7% | 47.8% |
| FDA Approval Date | Dec 22, 2022 | N/A |
| Manufacturer | Gilead Sciences, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |